Brazilian health regulator Anvisa denied Indian laboratory Bharat Biotech a certificate of best practices to produce medicines, a requirement to allow the import of Covid-19 vaccine Covaxin.
The decision was published on Brazil’s Federal Register on Tuesday morning. The regulator said the laboratory “did not fulfill manufacturing best practices.”
On Thursday, the federal government asked permission to import 20 million doses of Covaxin, hoping to receive 8 million shots before the end of March.
Search
